Pramlintide
Symlin · SymlinPen
A synthetic analog of human amylin, approved as an adjunct to mealtime insulin in type 1 and type 2 diabetes. Amylin is co-secreted with insulin, which is the pathway cagrilintide and petrelintide also target.
Tracking and educational reference only, on values you enter yourself. Not medical advice or a dosing recommendation.
Half-life
~48 min, subcutaneous. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Supplied as a solution in a pen-injector; refrigerated before first use, then stored per its label.
References
- FDA label: SymlinPen (NDA 021332)
Read the source
Related in GLP-1 / Metabolic
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.